Cosmetic Compliance
Intelligence & Solutions
Cosmetic
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
Home / Database / Regulatory Database
FAQs regarding the Processing of Manufacturing and Marketing Approval of Newly Designated Quasi-drugs
Local Title:
新指定医薬部外品の製造販売承認事務の取扱いに関する質疑応答集 （Ｑ＆Ａ）について
Country/Region:
Japan
Competent Authority:
Ministry of Health, Labour and Welfare
Type:
FAQ
Status:
In force
Release Date:
2017-03-31
Implementation Date:
2017-03-31
Document
Language Source Title Access
JA
 Official FAQs regarding the Processing of Manufacturing and Marketing Approval of Newly Designated Quasi-drugs
Download
On-demand Translation Service
FAQs regarding the Processing of Manufacturing and Marketing Approval of Newly Designated Quasi-drugs
Request
request
Summary

The FAQs regarding the Processing of Manufacturing and Marketing Approval of Newly Designated Quasi-drugs was released by MHLW on Mar. 31, 2017 and it encompasses 5 questions in terms of marketing/manufacturing approval of newly-designated quasi-drugs, efficacy claim and etc.